TIAA CREF Investment Management’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q1 | $2.8M | Hold |
511,523
| – | – | ﹤0.01% | 1811 |
|
2018
Q4 | $1.55M | Hold |
511,523
| – | – | ﹤0.01% | 2100 |
|
2018
Q3 | $2.15M | Hold |
511,523
| – | – | ﹤0.01% | 2088 |
|
2018
Q2 | $1.98M | Sell |
511,523
-186,105
| -27% | -$719K | ﹤0.01% | 2179 |
|
2018
Q1 | $4.42M | Sell |
697,628
-3,138
| -0.4% | -$19.9K | ﹤0.01% | 1630 |
|
2017
Q4 | $5.65M | Sell |
700,766
-13,925
| -2% | -$112K | ﹤0.01% | 1534 |
|
2017
Q3 | $8.18M | Buy |
714,691
+7,483
| +1% | +$85.6K | 0.01% | 1277 |
|
2017
Q2 | $6.9M | Sell |
707,208
-104,340
| -13% | -$1.02M | ﹤0.01% | 1375 |
|
2017
Q1 | $19.7M | Sell |
811,548
-2,349
| -0.3% | -$56.9K | 0.01% | 757 |
|
2016
Q4 | $26.1M | Buy |
813,897
+75,855
| +10% | +$2.44M | 0.02% | 656 |
|
2016
Q3 | $36.9K | Buy |
738,042
+32,248
| +5% | +$1.61K | 0.02% | 539 |
|
2016
Q2 | $29.9M | Buy |
705,794
+11,129
| +2% | +$472K | 0.02% | 581 |
|
2016
Q1 | $45.7M | Buy |
694,665
+47,918
| +7% | +$3.16M | 0.04% | 459 |
|
2015
Q4 | $40.2M | Buy |
646,747
+66,586
| +11% | +$4.14M | 0.03% | 529 |
|
2015
Q3 | $38.8M | Buy |
580,161
+185,729
| +47% | +$12.4M | 0.03% | 518 |
|
2015
Q2 | $38.4M | Buy |
394,432
+66,843
| +20% | +$6.5M | 0.03% | 560 |
|
2015
Q1 | $30.6M | Buy |
327,589
+272,076
| +490% | +$25.4M | 0.02% | 634 |
|
2014
Q4 | $4.94M | Sell |
55,513
-2,811
| -5% | -$250K | ﹤0.01% | 1635 |
|
2014
Q3 | $4.03M | Sell |
58,324
-1,556
| -3% | -$107K | ﹤0.01% | 1767 |
|
2014
Q2 | $3.43M | Buy |
59,880
+1,153
| +2% | +$66.1K | ﹤0.01% | 1944 |
|
2014
Q1 | $2.33M | Buy |
58,727
+2,227
| +4% | +$88.3K | ﹤0.01% | 2148 |
|
2013
Q4 | $2.37M | Sell |
56,500
-1,766
| -3% | -$74.2K | ﹤0.01% | 2149 |
|
2013
Q3 | $1.74M | Buy |
58,266
+11,399
| +24% | +$341K | ﹤0.01% | 2302 |
|
2013
Q2 | $2.48M | Buy |
+46,867
| New | +$2.48M | ﹤0.01% | 2028 |
|